Chromosome translocations in sarcomas and the emergence of oncogenic transcription factors

European Journal of Cancer

Volumn 41, Issue 16, 2005, Pages 2513-2527

  Xia, Shujuan J ^a   Barr, Frederic G ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Chromosomal translocation; Fusion protein; Sarcoma; Transcription factor

Indexed keywords

CLTC ALK PROTEIN; COL1A1 PDGFB PROTEIN; ETV6 NTRK3 PROTEIN; EWS ATF1 PROTEIN; EWS CHN PROTEIN; EWS CHOP PROTEIN; EWS ERG PROTEIN; EWS ETV1 PROTEIN; EWS FEV PROTEIN; EWS WT1 PROTEIN; FLAVOPIRIDOL; FUS ATF1 PROTEIN; FUS CHOP PROTEIN; FUS CREB312 PROTEIN; FUS ERG PROTEIN; HYBRID PROTEIN; ONCOPROTEIN; PAX3 FKHR PROTEIN; POLYETHYLENEIMINE; PROTEIN P53; SYT SSX4 PROTEIN; TCF12 CHN PROTEIN; TFE3 ASPL PROTEIN; TPM3 ALK PROTEIN; TPM4 ALK PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FKHR; TRANSCRIPTION FACTOR PAX3; TRANSCRIPTION FACTOR PAX7; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; UNCLASSIFIED DRUG;

ALVEOLAR SOFT PART SARCOMA; CARCINOGENESIS; CELL DIFFERENTIATION; CHONDROSARCOMA; CHROMOSOME TRANSLOCATION; CLEAR CELL SARCOMA; DERMATOFIBROMA; DESMOPLASTIC SMALL ROUND CELL TUMOR; ENDOMETRIUM SARCOMA; EWING SARCOMA; FIBROSARCOMA; FUSION GENE; HISTIOCYTOMA; HUMAN; METASTASIS; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; ONCOGENE; PLASMA CELL GRANULOMA; PRIORITY JOURNAL; REVIEW; RHABDOMYOSARCOMA; RNA INTERFERENCE; SARCOMA; SYNOVIAL SARCOMA;

EID: 27544471889     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2005.08.003     Document Type: Article

References (137)

1. E.C. Borden, L.H. Baker, and R.S. Bell Soft tissue sarcomas of adults: state of the translational science Clin Cancer Res 9 6 2003 1941 1956
2. S. Scheidler, W.J. Fredericks, and F.J. Rauscher III The hybrid PAX3-FKHR fusion protein of alveolar rhabdomyosarcoma transforms fibroblasts in culture Proc Natl Acad Sci USA 93 18 1996 9805 9809
3. W.A. May, M.L. Gishizky, and S.L. Lessnick Ewing sarcoma 11;22 translocation produces a chimeric transcription factor that requires the DNA-binding domain encoded by FLI1 for transformation Proc Natl Acad Sci USA 90 12 1993 5752 5756
4. M. Nagai, S. Tanaka, and M. Tsuda Analysis of transforming activity of human synovial sarcoma-associated chimeric protein SYT-SSX1 bound to chromatin remodeling factor hBRM/hSNF2 alpha Proc Natl Acad Sci USA 98 7 2001 3843 3848
5. M.H. Schwarzbach, R. Koesters, and A. Germann Comparable transforming capacities and differential gene expression patterns of variant FUS/CHOP fusion transcripts derived from soft tissue liposarcomas Oncogene 23 40 2004 6798 6805
6. A. Arvand, S.M. Welford, and M.A. Teitell The COOH-terminal domain of FLI-1 is necessary for full tumourigenesis and transcriptional modulation by EWS/FLI-1 Cancer Res 61 13 2001 5311 5317
7. P.A. Perez-Mancera, J. Perez-Losada, and M. Sanchez-Martin Expression of the FUS domain restores liposarcoma development in CHOP transgenic mice Oncogene 21 11 2002 1679 1684
8. C. Keller, B.R. Arenkiel, and C.M. Coffin Alveolar rhabdomyosarcomas in conditional Pax3:Fkhr mice: cooperativity of Ink4a/ARF and Trp53 loss of function Genes Dev 18 21 2004 2614 2626
9. Y. Fujimura, H. Siddique, and L. Lee EWS-ATF-1 chimeric protein in soft tissue clear cell sarcoma associates with CREB-binding protein and interferes with p53-mediated trans-activation function Oncogene 20 46 2001 6653 6659
10. L.L. Knoop, and S.J. Baker The splicing factor U1C represses EWS/FLI-mediated transactivation J Biol Chem 275 32 2000 24865 24871
11. M. Fukuma, H. Okita, and J. Hata Upregulation of Id2, an oncogenic helix-loop-helix protein, is mediated by the chimeric EWS/ets protein in Ewing sarcoma Oncogene 22 1 2003 1 9
12. A.D. Thompson, M.A. Teitell, and A. Arvand Divergent Ewing's sarcoma EWS/ETS fusions confer a common tumourigenic phenotype on NIH3T3 cells Oncogene 18 40 1999 5506 5513
13. A. Rangarajan, S.J. Hong, and A. Gifford Species- and cell type-specific requirements for cellular transformation Cancer Cell 6 2 2004 171 183
14. A. Maitra, H. Roberts, and A.G. Weinberg Aberrant expression of tumour suppressor proteins in the Ewing family of tumours Arch Pathol Lab Med 125 9 2001 1207 1212
15. P. Dias, P. Kumar, and H.B. Marsden N-myc gene is amplified in alveolar rhabdomyosarcomas (RMS) but not in embryonal RMS Int J Cancer 45 4 1990 593 596
16. S.J. Xia, J.G. Pressey, and F.G. Barr Molecular pathogenesis of rhabdomyosarcoma Cancer Biol Ther 1 2 2002 97 104
17. F.G. Barr Molecular genetics and pathogenesis of rhabdomyosarcoma J Pediatr Hematol Oncol 19 6 1997 483 491
18. F.G. Barr, N. Galili, and J. Holick Rearrangement of the PAX3 paired box gene in the paediatric solid tumour alveolar rhabdomyosarcoma Nat Genet 3 2 1993 113 117
19. N. Galili, R.J. Davis, and W.J. Fredericks Fusion of a fork head domain gene to PAX3 in the solid tumour alveolar rhabdomyosarcoma Nat Genet 5 3 1993 230 235
20. R.J. Davis, C.M. D'Cruz, and M.A. Lovell Fusion of PAX7 to FKHR by the variant t(1;13)(p36;q14) translocation in alveolar rhabdomyosarcoma Cancer Res 54 11 1994 2869 2872
21. P. Tremblay, and P. Gruss Pax: genes for mice and men Pharmacol Ther 61 1-2 1994 205 226
22. A. Mansouri The role of Pax3 and Pax7 in development and cancer Crit Rev Oncog 9 2 1998 141 149
23. M. Tassabehji, A.P. Read, and V.E. Newton Waardenburg's syndrome patients have mutations in the human homologue of the Pax-3 paired box gene Nature 355 6361 1992 635 636
24. G. Chalepakis, M. Goulding, and A. Read Molecular basis of splotch and Waardenburg Pax-3 mutations Proc Natl Acad Sci USA 91 9 1994 3685 3689
25. A.G. Ridgeway, and I.S. Skerjanc Pax3 is essential for skeletal myogenesis and the expression of six1 and Eya2 J Biol Chem 276 2001 19033 19039
26. P. Seale, L.A. Sabourin, and A. Girgis-Gabardo Pax7 is required for the specification of myogenic satellite cells Cell 102 6 2000 777 786
27. S. Oustanina, G. Hause, and T. Braun Pax7 directs postnatal renewal and propagation of myogenic satellite cells but not their specification EMBO J 23 16 2004 3430 3439
28. A. Mansouri, A. Stoykova, and M. Torres Dysgenesis of cephalic neural crest derivatives in Pax7-/- mutant mice Development 122 3 1996 831 838
29. F. Relaix, M. Polimeni, and D. Rocancourt The transcriptional activator PAX3-FKHR rescues the defects of Pax3 mutant mice but induces a myogenic gain-of-function phenotype with ligand-independent activation of Met signalling in vivo Genes Dev 17 23 2003 2950 2965
30. D. Accili, and K.C. Arden FoxOs at the crossroads of cellular metabolism, differentiation, and transformation Cell 117 4 2004 421 426
31. P.R. Bois, and G.C. Grosveld FKHR (FOXO1a) is required for myotube fusion of primary mouse myoblasts EMBO J 22 5 2003 1147 1157
32. R.J. Davis, and F.G. Barr Fusion genes resulting from alternative chromosomal translocations are overexpressed by gene-specific mechanisms in alveolar rhabdomyosarcoma Proc Natl Acad Sci USA 94 15 1997 8047 8051
33. J.L. Bennicelli, S. Advani, and B.W. Schafer PAX3 and PAX7 exhibit conserved cis-acting transcription repression domains and utilize a common gain of function mechanism in alveolar rhabdomyosarcoma Oncogene 18 30 1999 4348 4356
34. J.L. Bennicelli, R.H. Edwards, and F.G. Barr Mechanism for transcriptional gain of function resulting from chromosomal translocation in alveolar rhabdomyosarcoma Proc Natl Acad Sci USA 93 11 1996 5455 5459
35. W.J. Fredericks, N. Galili, and S. Mukhopadhyay The PAX3-FKHR fusion protein created by the t(2;13) translocation in alveolar rhabdomyosarcomas is a more potent transcriptional activator than PAX3 Mol Cell Biol 15 3 1995 1522 1535
36. L. del Peso, V.M. Gonzalez, and R. Hernandez Regulation of the forkhead transcription factor FKHR, but not the PAX3- FKHR fusion protein, by the serine/threonine kinase Akt Oncogene 18 51 1999 7328 7333
37. P.Y. Lam, J.E. Sublett, and A.D. Hollenbach The oncogenic potential of the Pax3-FKHR fusion protein requires the Pax3 homeodomain recognition helix but not the Pax3 paired-box DNA binding domain Mol Cell Biol 19 1 1999 594 601
38. J. Anderson, A. Ramsay, and S. Gould Pax3-fkhr induces morphological change and enhances cellular proliferation and invasion in rhabdomyosarcoma Am J Pathol 159 3 2001 1089 1096
39. M. Bernasconi, A. Remppis, and W.J. Fredericks Induction of apoptosis in rhabdomyosarcoma cells through down-regulation of PAX proteins Proc Natl Acad Sci USA 93 23 1996 13164 136169
40. C.M. Margue, M. Bernasconi, and F.G. Barr Transcriptional modulation of the anti-apoptotic protein BCL-XL by the paired box transcription factors PAX3 and PAX3/FKHR Oncogene 19 25 2000 2921 2929
41. C. Birchmeier, W. Birchmeier, and E. Gherardi Met, metastasis, motility and more Nat Rev Mol Cell Biol 4 12 2003 915 925
42. F. Bladt, D. Riethmacher, and S. Isenmann Essential role for the c-met receptor in the migration of myogenic precursor cells into the limb bud Nature 376 6543 1995 768 771
43. J.A. Epstein, D.N. Shapiro, and J. Cheng Pax3 modulates expression of the c-Met receptor during limb muscle development Proc Natl Acad Sci USA 93 9 1996 4213 4218
44. J.P. Ginsberg, R.J. Davis, and J.L. Bennicelli Up-regulation of MET but not neural cell adhesion molecule expression by the PAX3-FKHR fusion protein in alveolar rhabdomyosarcoma Cancer Res 58 16 1998 3542 3546
45. K. Jankowski, M. Kucia, and M. Wysoczynski Both hepatocyte growth factor (HGF) and stromal-derived factor-1 regulate the metastatic behavior of human rhabdomyosarcoma cells, but only HGF enhances their resistance to radiochemotherapy Cancer Res 63 22 2003 7926 7935
46. M.A. Moore The role of chemoattraction in cancer metastases Bioessays 23 8 2001 674 676
47. P.M. Murphy Chemokines and the molecular basis of cancer metastasis N Engl J Med 345 11 2001 833 835
48. O. Tomescu, S.J. Xia, and D. Strezlecki Inducible short-term and stable long-term cell culture systems reveal that the PAX3-FKHR fusion oncoprotein regulates CXCR4, PAX3, and PAX7 expression Lab Invest 84 8 2004 1060 1070
49. J. Libura, J. Drukala, and M. Majka CXCR4-SDF-1 signalling is active in rhabdomyosarcoma cells and regulates locomotion, chemotaxis, and adhesion Blood 100 7 2002 2597 2606
50. J.A. Epstein, P. Lam, and L. Jepeal Pax3 inhibits myogenic differentiation of cultured myoblast cells J Biol Chem 270 20 1995 11719 11722
51. J. Khan, M.L. Bittner, and L.H. Saal cDNA microarrays detect activation of a myogenic transcription program by the PAX3-FKHR fusion oncogene Proc Natl Acad Sci USA 96 23 1999 13264 13269
52. M.J. Anderson, G.D. Shelton, and W.K. Cavenee Embryonic expression of the tumour-associated PAX3-FKHR fusion protein interferes with the developmental functions of Pax3 Proc Natl Acad Sci USA 98 4 2001 1589 1594
53. I. Lagutina, S.J. Conway, and J. Sublett Pax3-FKHR knock-in mice show developmental aberrations but do not develop tumours Mol Cell Biol 22 20 2002 7204 7216
54. S.J. Xia, and F.G. Barr Analysis of the transforming and growth suppressive activities of the PAX3-FKHR oncoprotein Oncogene 23 41 2004 6864 6871
55. A.T. Gordon, C. Brinkschmidt, and J. Anderson A novel and consistent amplicon at 13q31 associated with alveolar rhabdomyosarcoma Genes Chromosomes Cancer 28 2 2000 220 226
56. J.A. Bridge, J. Liu, and S.J. Qualman Genomic gains and losses are similar in genetic and histologic subsets of rhabdomyosarcoma, whereas amplification predominates in embryonal with anaplasia and alveolar subtypes Genes Chromosomes Cancer 33 3 2002 310 321
57. D.C. West Ewing sarcoma family of tumours Curr Opin Oncol 12 4 2000 323 329
58. J. Kim, and J. Pelletier Molecular genetics of chromosome translocations involving EWS and related family members Physiol Genom 1 3 1999 127 138
59. D.C. Shing, D.J. McMullan, and P. Roberts FUS/ERG gene fusions in Ewing's tumours Cancer Res 63 15 2003 4568 4576
60. T. Ohno, V.N. Rao, and E.S. Reddy EWS/Fli-1 chimeric protein is a transcriptional activator Cancer Res 53 24 1993 5859 5863
61. H. Zinszner, R. Albalat, and D. Ron A novel effector domain from the RNA-binding protein TLS or EWS is required for oncogenic transformation by CHOP Genes Dev 8 21 1994 2513 2526
62. H. Kovar, G. Jug, and C. Hattinger The EWS protein is dispensable for Ewing tumour growth Cancer Res 61 16 2001 5992 5997
63. B. Wasylyk, S.L. Hahn, and A. Giovane The Ets family of transcription factors Eur J Biochem 211 1-2 1993 7 18
64. X. Mao, S. Miesfeldt, and H. Yang The FLI-1 and chimeric EWS-FLI-1 oncoproteins display similar DNA binding specificities J Biol Chem 269 27 1994 18216 18222
65. R.A. Bailly, R. Bosselut, and J. Zucman DNA-binding and transcriptional activation properties of the EWS-FLI-1 fusion protein resulting from the t(11;22) translocation in Ewing sarcoma Mol Cell Biol 14 5 1994 3230 3241
66. D. Chan, T.J. Wilson, and D. Xu Transformation induced by Ewing's sarcoma associated EWS/FLI-1 is suppressed by KRAB/FLI-1 Br J Cancer 88 1 2003 137 145
67. H. Kovar, D.N. Aryee, and G. Jug EWS/FLI-1 antagonists induce growth inhibition of Ewing tumour cells in vitro Cell Growth Differ 7 4 1996 429 437
68. M. Ouchida, T. Ohno, and Y. Fujimura Loss of tumourigenicity of Ewing's sarcoma cells expressing antisense RNA to EWS-fusion transcripts Oncogene 11 6 1995 1049 1054
69. G. Lambert, J.R. Bertrand, and E. Fattal EWS fli-1 antisense nanocapsules inhibits ewing sarcoma-related tumour in mice Biochem Biophys Res Commun 279 2 2000 401 406
70. H.A. Chansky, F. Barahmand-Pour, and Q. Mei Targeting of EWS/FLI-1 by RNA interference attenuates the tumour phenotype of Ewing's sarcoma cells in vitro J Orthop Res 22 4 2004 910 917
71. A. Prieur, F. Tirode, and P. Cohen EWS/FLI-1 silencing and gene profiling of Ewing cells reveal downstream oncogenic pathways and a crucial role for repression of insulin-like growth factor binding protein 3 Mol Cell Biol 24 16 2004 7275 7283
72. T. Dohjima, T. Ohno, and Y. Banno Preferential down-regulation of phospholipase C-beta in Ewing's sarcoma cells transfected with antisense EWS-Fli-1 Br J Cancer 82 1 2000 16 19
73. Y. Matsumoto, K. Tanaka, and F. Nakatani Downregulation and forced expression of EWS-Fli1 fusion gene results in changes in the expression of G(1)regulatory genes Br J Cancer 84 6 2001 768 775
74. F. Nakatani, K. Tanaka, and R. Sakimura Identification of p21WAF1/CIP1 as a direct target of EWS-Fli1 oncogenic fusion protein J Biol Chem 278 17 2003 15105 15115
75. J. Zhang, S. Hu, and D.E. Schofield Selective usage of D-Type cyclins by Ewing's tumours and rhabdomyosarcomas Cancer Res 64 17 2004 6026 6034
76. B. Fuchs, C.Y. Inwards, and R. Janknecht Vascular endothelial growth factor expression is up-regulated by EWS-ETS oncoproteins and Sp1 and may represent an independent predictor of survival in Ewing's sarcoma Clin Cancer Res 10 4 2004 1344 1353
77. H. Nishimori, Y. Sasaki, and K. Yoshida The Id2 gene is a novel target of transcriptional activation by EWS-ETS fusion proteins in Ewing family tumours Oncogene 21 54 2002 8302 8309
78. K.B. Hahm, K. Cho, and C. Lee Repression of the gene encoding the TGF-beta type II receptor is a major target of the EWS-FLI1 oncoprotein Nat Genet 23 2 1999 222 227
79. Y.H. Im, H.T. Kim, and C. Lee EWS-FLI1, EWS-ERG, and EWS-ETV1 oncoproteins of Ewing tumour family all suppress transcription of transforming growth factor beta type II receptor gene Cancer Res 60 6 2000 1536 1540
80. J.A. Toretsky, T. Kalebic, and V. Blakesley The insulin-like growth factor-I receptor is required for EWS/FLI-1 transformation of fibroblasts J Biol Chem 272 49 1997 30822 30827
81. J.W. Shay Telomerase in human development and cancer J Cell Physiol 173 2 1997 266 270
82. A. Takahashi, F. Higashino, and M. Aoyagi EWS/ETS fusions activate telomerase in Ewing's tumours Cancer Res 63 23 2003 8338 8344
83. S. Eliazer, J. Spencer, and D. Ye Alteration of mesodermal cell differentiation by EWS/FLI-1, the oncogene implicated in Ewing's sarcoma Mol Cell Biol 23 2 2003 482 492
84. C.J. Rorie, V.D. Thomas, and P. Chen The Ews/Fli-1 fusion gene switches the differentiation program of neuroblastomas to Ewing sarcoma/peripheral primitive neuroectodermal tumours Cancer Res 64 4 2004 1266 1277
85. C.J. Rorie, and B.E. Weissman The Ews/Fli-1 fusion gene changes the status of p53 in neuroblastoma tumour cell lines Cancer Res 64 20 2004 7288 7295
86. S.Y. Shieh, M. Ikeda, and Y. Taya DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2 Cell 91 3 1997 325 334
87. B. Deneen, and C.T. Denny Loss of p16 pathways stabilizes EWS/FLI1 expression and complements EWS/FLI1 mediated transformation Oncogene 20 46 2001 6731 6741
88. S.L. Lessnick, C.S. Dacwag, and T.R. Golub The Ewing's sarcoma oncoprotein EWS/FLI induces a p53-dependent growth arrest in primary human fibroblasts Cancer Cell 1 4 2002 393 401
89. J. Zucman, O. Delattre, and C. Desmaze EWS and ATF-1 gene fusion induced by t(12;22) translocation in malignant melanoma of soft parts Nat Genet 4 4 1993 341 345
90. Y. Fujimura, T. Ohno, and H. Siddique The EWS-ATF-1 gene involved in malignant melanoma of soft parts with t(12;22) chromosome translocation, encodes a constitutive transcriptional activator Oncogene 12 1 1996 159 167
91. M. Jishage, T. Fujino, and Y. Yamazaki Identification of target genes for EWS/ATF-1 chimeric transcription factor Oncogene 22 1 2003 41 49
92. J.M. Bosilevac, R.J. Olsen, and J.A. Bridge Tumour cell viability in clear cell sarcoma requires DNA binding activity of the EWS/ATF1 fusion protein J Biol Chem 274 49 1999 34811 34818
93. M. Ladanyi, and W. Gerald Fusion of the EWS and WT1 genes in the desmoplastic small round cell tumour Cancer Res 54 11 1994 2837 2840
94. W.L. Gerald, J. Rosai, and M. Ladanyi Characterization of the genomic breakpoint and chimeric transcripts in the EWS-WT1 gene fusion of desmoplastic small round cell tumour Proc Natl Acad Sci USA 92 4 1995 1028 1032
95. J.C. Wong, S.B. Lee, and M.D. Bell Induction of the interleukin-2/15 receptor beta-chain by the EWS-WT1 translocation product Oncogene 21 13 2002 2009 2019
96. V.A. Soldatenkov, I.N. Trofimova, and A. Rouzaut Differential regulation of the response to DNA damage in Ewing's sarcoma cells by ETS1 and EWS/FLI-1 Oncogene 21 18 2002 2890 2895
97. R.E. Palmer, S.B. Lee, and J.C. Wong Induction of BAIAP3 by the EWS-WT1 chimeric fusion implicates regulated exocytosis in tumourigenesis Cancer Cell 2 6 2002 497 505
98. S.B. Lee, K.A. Kolquist, and K. Nichols The EWS-WT1 translocation product induces PDGFA in desmoplastic small round-cell tumour Nat Genet 17 3 1997 309 313
99. P.A. Reynolds, G.A. Smolen, and R.E. Palmer Identification of a DNA-binding site and transcriptional target for the EWS-WT1(+KTS) oncoprotein Genes Dev 17 17 2003 2094 2107
100. B. Kobe, and J. Deisenhofer Proteins with leucine-rich repeats Curr Opin Struct Biol 5 3 1995 409 416
101. J.C. Knight, P.J. Renwick, and P.D. Cin Translocation t(12;16)(q13;p11) in myxoid liposarcoma and round cell liposarcoma: molecular and cytogenetic analysis Cancer Res 55 1 1995 24 27
102. H. Kanoe, T. Nakayama, and T. Hosaka Characteristics of genomic breakpoints in TLS-CHOP translocations in liposarcomas suggest the involvement of Translin and topoisomerase II in the process of translocation Oncogene 18 3 1999 721 729
103. I. Panagopoulos, F. Mertens, and M. Isaksson A novel FUS/CHOP chimera in myxoid liposarcoma Biochem Biophys Res Commun 279 3 2000 838 845
104. A. Crozat, P. Aman, and N. Mandahl Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma Nature 363 6430 1993 640 644
105. M. Kuroda, T. Ishida, and M. Takanashi Oncogenic transformation and inhibition of adipocytic conversion of preadipocytes by TLS/FUS-CHOP type II chimeric protein Am J Pathol 151 3 1997 735 744
106. J. Perez-Losada, B. Pintado, and A. Gutierrez-Adan The chimeric FUS/TLS-CHOP fusion protein specifically induces liposarcomas in transgenic mice Oncogene 19 20 2000 2413 2422
107. J. Perez-Losada, M. Sanchez-Martin, and M.A. Rodriguez-Garcia Liposarcoma initiated by FUS/TLS-CHOP: the FUS/TLS domain plays a critical role in the pathogenesis of liposarcoma Oncogene 19 52 2000 6015 6022
108. A. Maksimenko, G. Lambert, and J.R. Bertrand Therapeutic potentialities of EWS-Fli-1 mRNA-targeted vectorized antisense oligonucleotides Ann N Y Acad Sci 1002 2003 72 77
109. G.J. Hannon RNA interference Nature 418 6894 2002 244 251
110. B. Deneen, H. Hamidi, and C.T. Denny Functional analysis of the EWS/ETS target gene uridine phosphorylase Cancer Res 63 14 2003 4268 4274
111. X. Lu, A. Pearson, and J. Lunec The MYCN oncoprotein as a drug development target Cancer Lett 197 1-2 2003 125 130
112. F. Blasco, S. Penuelas, and M. Cascallo Expression profiles of a human pancreatic cancer cell line upon induction of apoptosis search for modulators in cancer therapy Oncology 67 3-4 2004 277 290
113. R. Hosotani, Y. Miyamoto, and K. Fujimoto Trojan p16 peptide suppresses pancreatic cancer growth and prolongs survival in mice Clin Cancer Res 8 4 2002 1271 1276
114. S.E. Barrie, E. Eno-Amooquaye, and A. Hardcastle High-throughput screening for the identification of small-molecule inhibitors of retinoblastoma protein phosphorylation in cells Anal Biochem 320 1 2003 66 74
115. A.M. Senderowicz Small molecule modulators of cyclin-dependent kinases for cancer therapy Oncogene 19 56 2000 6600 6606
116. A. Ndoye, J.L. Merlin, and A. Leroux Enhanced gene transfer and cell death following p53 gene transfer using photochemical internalisation of glucosylated PEI-DNA complexes J Gene Med 6 8 2004 884 894
117. L.T. Vassilev, B.T. Vu, and B. Graves In vivo activation of the p53 pathway by small-molecule antagonists of MDM2 Science 303 5659 2004 844 848
118. N. Issaeva, P. Bozko, and M. Enge Small molecule RITA binds to p53, blocks p53-HDM-2 interaction and activates p53 function in tumours Nat Med 10 12 2004 1321 1328
119. M. Ladanyi, M.Y. Lui, and C.R. Antonescu The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25 Oncogene 20 1 2001 48 57
120. B.L. Waters, I. Panagopoulos, and E.F. Allen Genetic characterization of angiomatoid fibrous histiocytoma identifies fusion of the FUS and ATF-1 genes induced by a chromosomal translocation involving bands 12q13 and 16p11 Cancer Genet Cytogenet 121 2 2000 109 116
121. M.P. Simon, F. Pedeutour, and N. Sirvent Deregulation of the platelet-derived growth factor B-chain gene via fusion with collagen gene COL1A1 in dermatofibrosarcoma protuberans and giant-cell fibroblastoma Nat Genet 15 1 1997 95 98
122. J.I. Koontz, A.L. Soreng, and M. Nucci Frequent fusion of the JAZF1 and JJAZ1 genes in endometrial stromal tumours Proc Natl Acad Sci USA 98 11 2001 6348 6353
123. O. Delattre, J. Zucman, and B. Plougastel Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours Nature 359 6391 1992 162 165
124. J. Zucman, T. Melot, and C. Desmaze Combinatorial generation of variable fusion proteins in the Ewing family of tumours EMBO J 12 12 1993 4481 4487
125. I.S. Jeon, J.N. Davis, and B.S. Braun A variant Ewing's sarcoma translocation (7;22) fuses the EWS gene to the ETS gene ETV1 Oncogene 10 6 1995 1229 1234
126. Y. Kaneko, K. Yoshida, and M. Handa Fusion of an ETS-family gene, EIAF, to EWS by t(17;22)(q12;q12) chromosome translocation in an undifferentiated sarcoma of infancy Genes Chromosomes Cancer 15 2 1996 115 121
127. M. Peter, J. Couturier, and H. Pacquement A new member of the ETS family fused to EWS in Ewing tumours Oncogene 14 10 1997 1159 1164
128. S.R. Knezevich, D.E. McFadden, and W. Tao A novel ETV6-NTRK3 gene fusion in congenital fibrosarcoma Nat Genet 18 2 1998 184 187
129. B. Lawrence, A. Perez-Atayde, and M.K. Hibbard TPM3-ALK and TPM4-ALK oncogenes in inflammatory myofibroblastic tumours Am J Pathol 157 2 2000 377 384
130. J.A. Bridge, M. Kanamori, and Z. Ma Fusion of the ALK gene to the clathrin heavy chain gene, CLTC, in inflammatory myofibroblastic tumour Am J Pathol 159 2 2001 411 415
131. I. Panagopoulos, C. Tiziana Storlazzi, and C.D. Fletcher The chimeric FUS/CREB3l2 gene is specific for low-grade fibromyxoid sarcoma Genes Chromosomes Cancer 40 3 2004 218 228
132. Y. Labelle, J. Zucman, and G. Stenman Oncogenic conversion of a novel orphan nuclear receptor by chromosome translocation Hum Mol Genet 4 12 1995 2219 2226
133. H. Sjogren, J. Meis-Kindblom, and L.G. Kindblom Fusion of the EWS-related gene TAF2N to TEC in extraskeletal myxoid chondrosarcoma Cancer Res 59 20 1999 5064 5067
134. H. Sjogren, B. Wedell, and J.M. Kindblom Fusion of the NH2-terminal domain of the basic helix-loop-helix protein TCF12 to TEC in extraskeletal myxoid chondrosarcoma with translocation t(9;15)(q22;q21) Cancer Res 60 24 2000 6832 6835
135. I. Panagopoulos, M. Hoglund, and F. Mertens Fusion of the EWS and CHOP genes in myxoid liposarcoma Oncogene 12 3 1996 489 494
136. A.J. Crew, J. Clark, and C. Fisher Fusion of SYT to two genes, SSX1 and SSX2, encoding proteins with homology to the Kruppel-associated box in human synovial sarcoma EMBO J 14 10 1995 2333 2340
137. B. Skytting, G. Nilsson, and B. Brodin A novel fusion gene, SYT-SSX4, in synovial sarcoma J Natl Cancer Inst 91 11 1999 974 975